Literature DB >> 32082824

Our early and mid-term results for endovascular repair of abdominal aortic aneurysms.

Sedat Ozan Karakişi1, Şaban Ergene1, Doğuş Hemşinli1, Şeref Alp Küçüker2.   

Abstract

BACKGROUND: In this study, we present our early and mid-term results of endovascular aneurysm repair in patients with infrarenal abdominal aortic aneurysms.
METHODS: Between December 2011 and January 2017, a total of 154 patients (136 males, 18 females; mean age 71.7 years; range, 55 to 94 years) who underwent endovascular aneurysm repair were retrospectively analyzed. Data including demographic characteristics of the patients, pre-procedural additional diagnoses, mortality and morbidity rates, length of intensive care unit and hospital stays, amounts of blood products used, complications and reinterventions were recorded.
RESULTS: Seven patients underwent intervention in the emergency setting due to aneurysm rupture, while 147 patients received elective surgery. The mean follow-up was 35 (range, 12 to 72) months, the mean length of intensive care unit stay was 1.1 (range, 1 to 4) days, and the mean length of hospital stay was 3.1 (range, 3 to 7) days. A mean 0.3 units of erythrocyte suspension was used during the treatment. Endoleak developed in 16 patients, occlusion in the graft leg in two patients, increased aneurysmal diameter in six patients, and wound healing problems in five patients. Cross femoral bypass was applied in two patients, balloon dilation in three patients, proximal extension in three patients, and distal extension in four patients. Intraoperative mortality occurred in one patient. The total mortality rate was 7% and first 30-day mortality rate was 2%.
CONCLUSION: Our study results suggest that endovascular aneurysm repair has certain advantages including a low operative mortality rate, short intensive care unit and hospital stays, and less blood product use. In addition, this technique can be performed with regional anesthesia in high-risk comorbid patients.
Copyright © 2019, Turkish League Against Rheumatism.

Entities:  

Keywords:  Abdominal aortic aneurysm; endovascular aortic repair; stent graft

Year:  2019        PMID: 32082824      PMCID: PMC7021376          DOI: 10.5606/tgkdc.dergisi.2019.16328

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  15 in total

1.  A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients.

Authors:  Jean-Pierre Becquemin; Jean-Chistophe Pillet; François Lescalie; Marc Sapoval; Yann Goueffic; Patrick Lermusiaux; Eric Steinmetz; Jean Marzelle
Journal:  J Vasc Surg       Date:  2011-01-26       Impact factor: 4.268

2.  Long-term outcome of open or endovascular repair of abdominal aortic aneurysm.

Authors:  Jorg L De Bruin; Annette F Baas; Jaap Buth; Monique Prinssen; Eric L G Verhoeven; Philippe W M Cuypers; Marc R H M van Sambeek; Ron Balm; Diederick E Grobbee; Jan D Blankensteijn
Journal:  N Engl J Med       Date:  2010-05-20       Impact factor: 91.245

3.  Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.

Authors:  Rajesh Patel; Michael J Sweeting; Janet T Powell; Roger M Greenhalgh
Journal:  Lancet       Date:  2016-10-12       Impact factor: 79.321

Review 4.  Sexual Dysfunction After Abdominal Aortic Aneurysm Surgical Repair: Current Knowledge and Future Directions.

Authors:  Pierre Regnier; Fabien Lareyre; Réda Hassen-Khodja; Matthieu Durand; Joseph Touma; Juliette Raffort
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-12-29       Impact factor: 7.069

5.  Influence of anesthesia type on outcome after endovascular aortic aneurysm repair: an analysis based on EUROSTAR data.

Authors:  Volker Ruppert; Lina J Leurs; Bernd Steckmeier; Jacob Buth; Thomas Umscheid
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

Review 6.  Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry.

Authors:  Mahmoud B Malas; Julie A Freischlag
Journal:  Semin Vasc Surg       Date:  2010-09       Impact factor: 1.000

7.  Replanting the inferior mesentery artery during infrarenal aortic aneurysm repair: influence on postoperative colon ischemia.

Authors:  Christian Senekowitsch; Afshin Assadian; Ojan Assadian; Helmut Hartleb; Hermann Ptakovsky; Georg W Hagmüller
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

8.  Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.

Authors:  R M Greenhalgh; L C Brown; G P S Kwong; J T Powell; S G Thompson
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

9.  Long-term comparison of endovascular and open repair of abdominal aortic aneurysm.

Authors:  Frank A Lederle; Julie A Freischlag; Tassos C Kyriakides; Jon S Matsumura; Frank T Padberg; Ted R Kohler; Panagiotis Kougias; Jessie M Jean-Claude; Dolores F Cikrit; Kathleen M Swanson
Journal:  N Engl J Med       Date:  2012-11-22       Impact factor: 91.245

10.  Transfemoral intraluminal graft implantation for abdominal aortic aneurysms.

Authors:  J C Parodi; J C Palmaz; H D Barone
Journal:  Ann Vasc Surg       Date:  1991-11       Impact factor: 1.466

View more
  2 in total

1.  A novel method for cannulation of the short limb of aortic stent grafts during endovascular aneurysm repair: Göçer technique.

Authors:  Hakan Göçer; Ahmet Barış Durukan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-10-21       Impact factor: 0.332

2.  Elective Endovascular Repair of Abdominal Aortic Aneurysms with Modular and Unibody Type Endografts.

Authors:  Bekir Boğaçhan Akkaya; Ertekin Utku Ünal; Erman Sureyya Kiriş; Mehmet Hamdi Özbek; İsa Civelek; Veysel Başar; Göktan Aşkın; Ufuk Tütün; Hakkı Zafer İşcan
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.